Compounds > 20-hydroxy-5,8,11,14-eicosatetraenoic acid
Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and calcimycin

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with calcimycin in 1 studies

Compound Research Comparison

Studies
(20-hydroxy-5,8,11,14-eicosatetraenoic acid)		Trials
(20-hydroxy-5,8,11,14-eicosatetraenoic acid)		Recent Studies (post-2010)
(20-hydroxy-5,8,11,14-eicosatetraenoic acid)		Studies
(calcimycin)		Trials
(calcimycin)		Recent Studies (post-2010) (calcimycin)
6401323311,94640444

Protein Interaction Comparison

ProteinTaxonomy20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50)calcimycin (IC50)
XBP1Homo sapiens (human)1.41
DNA damage-inducible transcript 3 proteinMus musculus (house mouse)0.16

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campbell, WB; Dellsperger, KC; Falck, JR; Fang, X; Gopal, VR; Harmon, SD; Kaduce, TL; Oltman, CL; Spector, AA; Teesch, LM; Weintraub, NL1

Other Studies

1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and calcimycin

ArticleYear
20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells.
    The Journal of biological chemistry, 2004, Jan-23, Volume: 279, Issue:4

    Topics: Animals; Biological Transport, Active; Calcimycin; Coronary Vessels; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Ionophores; Swine; Time Factors

2004